Traynor Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-13,404
| Closed | -$537K | – | 160 |
|
|
2016
Q4 | $537K | Sell |
13,404
-2,092
| -14% | -$83.8K | 0.36% | 64 |
|
|
2016
Q3 | $686K | Sell |
15,496
-750
| -5% | -$33.2K | 0.48% | 46 |
|
|
2016
Q2 | $744K | Sell |
16,246
-3,000
| -16% | -$137K | 0.58% | 40 |
|
|
2016
Q1 | $761K | Sell |
19,246
-16,185
| -46% | -$640K | 0.61% | 36 |
|
|
2015
Q4 | $2M | Buy |
35,431
+1,835
| +5% | +$104K | 1.44% | 17 |
|
|
2015
Q3 | $1.34M | Buy |
33,596
+505
| +2% | +$20.1K | 1.15% | 20 |
|
|
2015
Q2 | $1.58M | Buy |
33,091
+606
| +2% | +$28.9K | 1.32% | 14 |
|
|
2015
Q1 | $1.29M | Buy |
32,485
+15,815
| +95% | +$628K | 1.24% | 14 |
|
|
2014
Q4 | $372K | Buy |
+16,670
| New | +$372K | 0.43% | 56 |
|